For Manuscript Submission, Check or Review Login please go to Submission Websites List.
For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.
Wirksamkeit von Arnica bei Varizenoperation: Ergebnisse einer randomisierten, doppelblinden, Placebo-kontrollierten Pilot-StudieWolf M.a · Tamaschke C.b · Mayer W.c · Heger M.d
aPraxis für Homöopathie, Berlin-Karow; bPraxis für Gefässerkrankungen, Berlin-Buch; cClinical Study Monitoring, Walldorf-Heidelberg; dForschungszentrum HomInt, Karlsruhe, Deutschland
Efficacy of Arnica in Varicose Vein Surgery: Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Trial Introduction: In homeopathy Arnica is widely used as a woundhealing medication and for the treatment of hematomas. Objective: In this pilot study the efficacy and safety of Arnica D12 in patients following varicose vein surgery were investigated. Design: Prospective, randomized, double-blind, placebo-controlled pilot trial according to ICH GCP guidelines. Setting: The study was conducted by a surgeon at the Angiosurgical Clinic, Berlin- Buch. Intervention: After randomized allocation, 60 patients received either Arnica D12 or placebo. Start of medication occurred the evening before operation with 5 globules. On the operation day one preoperative and hourly postoperative dosages after awakening were given. On days 2–14 of the study 5 globules 3 times a day were given. Outcome Criteria: Surface (in cm² and using a three-point verbal rating scale) and intensity of hematomas induced by operation, complications of wound healing, and intensity of pain (five-point verbal rating scale) as well as efficacy and safety of the study medication were assessed. Results: Hematoma surface was reduced (from day 7 to day 14) under Arnica by 75.5% and under placebo by 71.5% (p = 0.4726). The comparison of hematoma surface (small, medium, large) using the verbal rating scale yielded a value of p = 0.1260. Pain score decreased by 1.0 ± 2.2 points under Arnica and 0.3 ± 0.8 points under placebo (p = 0.1977). Remission or improvement of pain was observed in 43.3% of patients in the Arnica group and in 27.6% of patients in the placebo group. Tolerability was rated as very good in all cases. Conclusion: The results of this pilot study showed a trend towards a beneficial effect of Arnica D12 with regard to reduction of hematoma and pain during the postoperative course. For a statistically significant proof of efficacy of Arnica D12 in patients following varicose vein surgery a larger sample size is necessary.
© 2003 S. Karger GmbH, Freiburg